documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
9 rows where docket_id = "FDA-2024-P-3571" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-P-3571-0009 | FDA | None FDA-2024-P-3571 | Final Response Letter from FDA CDER to Premier Consulting | Other | Approval | 2024-12-26T05:00:00Z | 2024 | 12 | 2024-12-26T05:00:00Z | 2024-12-26T18:29:17Z | 0 | 0 | 090000648688c4f5 | ||
| FDA-2024-P-3571-0008 | FDA | None FDA-2024-P-3571 | Amendment to Suitability Petition from Premier Consulting | Other | Amendment | 2024-12-02T05:00:00Z | 2024 | 12 | 2024-12-02T05:00:00Z | 2024-12-02T19:02:50Z | 0 | 0 | 0900006486844a93 | ||
| FDA-2024-P-3571-0007 | FDA | None FDA-2024-P-3571 | Amendment to Suitability Petition from Premier Consulting | Other | Amendment | 2024-11-13T05:00:00Z | 2024 | 11 | 2024-11-13T05:00:00Z | 2024-11-13T15:18:24Z | 0 | 0 | 0900006486812ab5 | ||
| FDA-2024-P-3571-0006 | FDA | None FDA-2024-P-3571 | Completeness Assessment Correspondence | Other | Assessment Document or Analysis | 2024-08-16T04:00:00Z | 2024 | 8 | 2024-08-16T04:00:00Z | 2024-08-16T15:23:47Z | 0 | 0 | 090000648664df09 | ||
| FDA-2024-P-3571-0004 | FDA | None FDA-2024-P-3571 | Appendix 2 - FDA Orange Book – LOTREL (accessed 18 June 2024) | Supporting & Related Material | Background Material | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T17:31:41Z | 0 | 0 | 090000648660e567 | |||
| FDA-2024-P-3571-0005 | FDA | None FDA-2024-P-3571 | Appendix 3 - Proposed Draft Labeling for the Amlodipine and Benazepril hydrochloride Oral Liquid Product | Supporting & Related Material | Background Material | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T17:31:48Z | 0 | 0 | 090000648660e568 | |||
| FDA-2024-P-3571-0002 | FDA | None FDA-2024-P-3571 | Acknowledgment Letter from FDA DMS to Premier Consulting | Other | Acknowledgement Letter/Receipt | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T04:00:00Z | 2024-07-30T17:31:24Z | 0 | 0 | 090000648660e29e | ||
| FDA-2024-P-3571-0001 | FDA | None FDA-2024-P-3571 | Suitability Petition from Premier Consulting | Other | Petition(s) | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T04:00:00Z | 2024-12-26T18:08:50Z | 0 | 0 | 090000648660e29c | ||
| FDA-2024-P-3571-0003 | FDA | None FDA-2024-P-3571 | Appendix 1 - Approved Product Labeling – LOTREL | Supporting & Related Material | Background Material | 2024-07-30T04:00:00Z | 2024 | 7 | 2024-07-30T17:31:36Z | 0 | 0 | 090000648660e566 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;